ENHANZE® drug delivery technology : advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20 /
'ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20' provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the S...
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Libro |
| Lenguaje: | English |
| Publicado: |
UK :
Karger,
2022.
|
| Materias: | |
| Acceso en línea: | Ver documento en línea |
| Sumario: | 'ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20' provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the SC space, and a comprehensive overview on the history of hyaluronidases and the development of recombinant human hyaluronidase PH20 (rHuPH20). Current applications of rHuPH20 as well as approved biotherapeutics utilizing HuPH20-facilitated SC drug delivery are summarized, and the underlying non-clinical and clinical development approaches are introduced as a basis for future application to biologics in various disease areas. |
|---|---|
| Descripción Física: | 1 recurso en línea (104 páginas) : ilustraciones a color, archivo de texto, PDF. |
| ISBN: | 9783318070873 9783318070767 |
| Acceso: | Acceso al texto completo para la comunidad de la UCR por medio de la cuenta institucional |